{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:28:30Z","timestamp":1785446910960,"version":"3.56.0"},"reference-count":54,"publisher":"The Japanese Society for Neuroendovascular Therapy","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NOUSHINKEI KEKKANNAI TIRYOU","JNET"],"published-print":{"date-parts":[[2025]]},"DOI":"10.5797\/jnet.ra.2024-0014","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T22:16:39Z","timestamp":1713219399000},"page":"n\/a","source":"Crossref","is-referenced-by-count":8,"title":["Antithrombotic Therapy in Carotid Artery and Intracranial Artery Stent"],"prefix":"10.5797","volume":"19","author":[{"given":"Ichiro","family":"Nakagawa","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kotsugi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Maeoka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Morisaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University, Kashihara, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3804","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dalainas I, Nano G, Bianchi P, et al. Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting. <i>Cardiovasc Intervent Radiol<\/i> 2006; 29: 519\u2013521.","DOI":"10.1007\/s00270-005-5288-y"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sussman ES, Jin M, Pendharkar AV, et al. Dual antiplatelet therapy after carotid artery stenting: trends and outcomes in a large national database. <i>J Neurointerv Surg<\/i> 2021; 13: 8\u201313.","DOI":"10.1136\/neurintsurg-2020-016008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Abdul Rahman L, Turan TN, Cotsonis G, et al. Dual antiplatelet therapy beyond 90 days in symptomatic intracranial stenosis in the SAMMPRIS trial. <i>J Stroke Cerebrovasc Dis<\/i> 2020; 29: 105254.","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105254"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nakagawa I, Park HS, Wada T, et al. Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting. <i>Neurol Res<\/i> 2017; 39: 695\u2013701.","DOI":"10.1080\/01616412.2017.1301042"},{"key":"5","unstructured":"5) Bhatt DL, Kapadia SR, Bajzer CT, et al. Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. <i>J Invasive Cardiol<\/i> 2001; 13: 767\u2013771."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Chaturvedi S, Yadav JS. The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention. <i>Stroke<\/i> 2006; 37: 1572\u20131577.","DOI":"10.1161\/01.STR.0000221298.43117.be"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fifi JT, Brockington C, Narang J, et al. Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting. <i>AJNR Am J Neuroradiol<\/i> 2013; 34: 716\u2013720.","DOI":"10.3174\/ajnr.A3405"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sch\u00f6mig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. <i>N Engl J Med<\/i> 1996; 334: 1084\u20131089.","DOI":"10.1056\/NEJM199604253341702"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Enomoto Y, Yoshimura S. Antiplatelet therapy for carotid artery stenting. <i>Interv Neurol<\/i> 2013; 1: 151\u2013163.","DOI":"10.1159\/000351686"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) McKevitt FM, Randall MS, Cleveland TJ, et al. The benefits of combined anti-platelet treatment in carotid artery stenting. <i>Eur J Vasc Endovasc Surg<\/i> 2005; 29: 522\u2013527.","DOI":"10.1016\/j.ejvs.2005.01.012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tokuda R, Yoshimura S, Uchida K, et al. Real-world experience of carotid artery stenting in Japan: analysis of 8458 cases from the JR-NET3 nationwide retrospective multi-center registries. <i>Neurol Med Chir (Tokyo)<\/i> 2019; 59: 117\u2013125.","DOI":"10.2176\/nmc.st.2018-0264"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Bates ER, Babb JD, Casey DE Jr., et al. ACCF\/SCAI\/SVMB\/SIR\/ASITN 2007 Clinical Expert Consensus Document on carotid stenting. <i>Vasc Med<\/i> 2007; 12: 35\u201383.","DOI":"10.1177\/1358863X06076103"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nakagawa I, Wada T, Park HS, et al. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis. <i>J Vasc Surg<\/i> 2014; 59: 761\u2013767.","DOI":"10.1016\/j.jvs.2013.09.011"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Miyazaki Y, Mori T, Iwata T, et al. Continuous daily use of cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions. <i>J Neurointerv Surg<\/i> 2016; 8: 471\u2013475.","DOI":"10.1136\/neurintsurg-2014-011565"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Yamagami H, Sakai N, Matsumaru Y, et al. Periprocedural cilostazol treatment and restenosis after carotid artery stenting: the Retrospective Study of In-Stent Restenosis after Carotid Artery Stenting (ReSISteR-CAS). <i>J Stroke Cerebrovasc Dis<\/i> 2012; 21: 193\u2013199.","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.06.007"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Takayama K, Taoka T, Nakagawa H, et al. Effect of cilostazol in preventing restenosis after carotid artery stenting using the carotid wallstent: a multicenter retrospective study. <i>AJNR Am J Neuroradiol<\/i> 2012; 33: 2167\u20132170.","DOI":"10.3174\/ajnr.A3127"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kubota Y, Kichikawa K, Uchida H, et al. Pharmacologic treatment of intimal hyperplasia after metallic stent placement in the peripheral arteries. An experimental study. <i>Invest Radiol<\/i> 1995; 30: 532\u2013537.","DOI":"10.1097\/00004424-199509000-00004"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tanaka T, Ishikawa T, Hagiwara M, et al. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. <i>Pharmacology<\/i> 1988; 36: 313\u2013320.","DOI":"10.1159\/000138400"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Huibers A, Halliday A, Bulbulia R, et al. Antiplatelet therapy in carotid artery stenting and carotid endarterectomy in the asymptomatic carotid surgery trial-2. <i>Eur J Vasc Endovasc Surg<\/i> 2016; 51: 336\u2013342.","DOI":"10.1016\/j.ejvs.2015.11.002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Jhang KM, Huang JY, Nfor ON, et al. Is extended duration of dual antiplatelet therapy after carotid stenting beneficial? <i>Medicine (Baltimore)<\/i> 2015; 94: e1355.","DOI":"10.1097\/MD.0000000000001355"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hoshino K, Horiuchi H, Tada T, et al. Clopidogrel resistance in Japanese patients scheduled for percutaneous coronary intervention. <i>Circ J<\/i> 2009; 73: 336\u2013342.","DOI":"10.1253\/circj.CJ-08-0559"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Fukushima-Uesaka H, Saito Y, Maekawa K, et al. Genetic variations and haplotypes of CYP2C19 in a Japanese population. <i>Drug Metab Pharmacokinet<\/i> 2005; 20: 300\u2013307.","DOI":"10.2133\/dmpk.20.300"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Peng W, Zhang Y, Lin B, et al. Clinical outcomes of individualized antiplatelet therapy based on platelet function test in patients after percutaneous coronary intervention: a systematic review and meta-analysis. <i>J Cardiovasc Pharmacol<\/i> 2023; 81: 270\u2013279.","DOI":"10.1097\/FJC.0000000000001393"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Mangiacapra F, Patti G, Barbato E, et al. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study. <i>JACC Cardiovasc Interv<\/i> 2012; 5: 281\u2013289.","DOI":"10.1016\/j.jcin.2012.01.009"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Patti G, Pasceri V, Vizzi V, et al. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study). <i>Am J Cardiol<\/i> 2011; 107: 995\u20131000.","DOI":"10.1016\/j.amjcard.2010.11.025"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Sorkin GC, Dumont TM, Wach MM, et al. Carotid artery stenting outcomes: do they correlate with antiplatelet response assays? <i>J Neurointerv Surg<\/i> 2014; 6: 373\u2013378.","DOI":"10.1136\/neurintsurg-2013-010771"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Muram S, Panchendrabose K, Eagles ME, et al. Natural history of antiplatelet nonresponders undergoing carotid artery stenting. <i>J Neurosurg<\/i> 2023; 139: 661\u2013669.","DOI":"10.3171\/2022.12.JNS222316"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Gonz\u00e1lez A, Moniche F, Cayuela A, et al. Antiplatelet effects of clopidogrel dose adjustment (75 mg\/d vs 150 mg\/d) after carotid stenting. <i>J Vasc Surg<\/i> 2014; 60: 428\u2013435.","DOI":"10.1016\/j.jvs.2014.01.068"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Gensicke H, van der Worp HB, Nederkoorn PJ, et al. Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk. <i>J Am Coll Cardiol<\/i> 2015; 65: 521\u2013529.","DOI":"10.1016\/j.jacc.2014.11.038"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Ghamraoui AK, Ricotta JJ 2nd. Outcomes and strategy of tailored antiplatelet therapy with ticagrelor in patients undergoing transcarotid artery revascularization. <i>J Vasc Surg<\/i> 2021; 73: 132\u2013141.","DOI":"10.1016\/j.jvs.2020.04.518"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Mazzaccaro D, Giannetta M, Ranucci M, et al. Clopidogrel resistance and ticagrelor replacement in dual antiplatelet therapy for carotid artery stenting. <i>Ann Vasc Surg<\/i> 2023; 90: 128\u2013136.","DOI":"10.1016\/j.avsg.2022.09.063"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Nii K, Takemura Y, Inoue R, et al. Safety of direct oral anticoagulant - and antiplatelet therapy in patients with atrial fibrillation treated by carotid artery stenting. <i>J Stroke Cerebrovasc Dis<\/i> 2020; 29: 104899.","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104899"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Huang YC, Huang YC, Cheng YC, et al. Choice of antithrombotic therapy for patients with atrial fibrillation undergoing carotid angioplasty and stenting: a nationwide population-based study. <i>Sci Rep<\/i> 2022; 12: 1417.","DOI":"10.1038\/s41598-022-05546-8"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Weller JM, Dorn F, Meissner JN, et al. Antithrombotic treatment and outcome after endovascular treatment and acute carotid artery stenting in stroke patients with atrial fibrillation. <i>Neurol Res Pract<\/i> 2022; 4: 42.","DOI":"10.1186\/s42466-022-00207-7"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Pardo-Galiana B, Medina-Rodriguez M, Millan-Vazquez M, et al. Antithrombotic treatment after carotid stenting in patients with concomitant atrial fibrillation. <i>AJNR Am J Neuroradiol<\/i> 2022; 43: 727\u2013730.","DOI":"10.3174\/ajnr.A7482"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Papanagiotou P, Haussen DC, Turjman F, et al. Carotid stenting with antithrombotic agents and intracranial thrombectomy leads to the highest recanalization rate in patients with acute stroke with tandem lesions. <i>JACC Cardiovasc Interv<\/i> 2018; 11: 1290\u20131299.","DOI":"10.1016\/j.jcin.2018.05.036"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Goyal M, Yoshimura S, Milot G, et al. Considerations for antiplatelet management of carotid stenting in the setting of mechanical thrombectomy: a Delphi consensus statement. <i>AJNR Am J Neuroradiol<\/i> 2020; 41: 2274\u20132279.","DOI":"10.3174\/ajnr.A6888"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Da Ros V, Scaggiante J, Sallustio F, et al. Carotid stenting and mechanical thrombectomy in patients with acute ischemic stroke and tandem occlusions: antithrombotic treatment and functional outcome. <i>AJNR Am J Neuroradiol<\/i> 2020; 41: 2088\u20132093.","DOI":"10.3174\/ajnr.A6768"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Heck DV, Brown MD. Carotid stenting and intracranial thrombectomy for treatment of acute stroke due to tandem occlusions with aggressive antiplatelet therapy may be associated with a high incidence of intracranial hemorrhage. <i>J Neurointerv Surg<\/i> 2015; 7: 170\u2013175.","DOI":"10.1136\/neurintsurg-2014-011224"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Delvoye F, Maier B, Escalard S, et al. Antiplatelet therapy during emergent extracranial internal carotid artery stenting: comparison of three intravenous antiplatelet perioperative strategies. <i>J Stroke Cerebrovasc Dis<\/i> 2021; 30: 105521.","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105521"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Marnat G, Finistis S, Moreno R, et al. Aspirin versus aggressive antiplatelet therapy for acute carotid stenting plus thrombectomy in tandem occlusions: ETIS Registry results. <i>J Neurointerv Surg<\/i> 2023; 15(e2): e248\u2013e254.","DOI":"10.1136\/jnis-2022-019527"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Pop R, Burel J, Finitsis SN, et al. Comparison of three antithrombotic strategies for emergent carotid stenting during stroke thrombectomy: a multicenter study. <i>J Neurointerv Surg<\/i> 2023; 15(e3): e388\u2013e395.","DOI":"10.1136\/jnis-2022-019875"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Hadler F, Singh R, Wiesmann M, et al. Increased rates of hemorrhages after endovascular stroke treatment with emergency carotid artery stenting and dual antiplatelet therapy. <i>Cerebrovasc Dis<\/i> 2021; 50: 162\u2013170.","DOI":"10.1159\/000512204"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Pop R, Hasiu A, Mangin PH, et al. Postprocedural antiplatelet treatment after emergent carotid stenting in tandem lesions stroke: impact on stent patency beyond day 1. <i>AJNR Am J Neuroradiol<\/i> 2021; 42: 921\u2013925.","DOI":"10.3174\/ajnr.A6993"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Hajiyev K, Henkes H, Hellstern V, et al. Is crash loading acceptable in carotid artery stenting?: results of antiplatelet crash loading vs. semi-crash vs. elective loading in a large study population. <i>Clin Neuroradiol<\/i> 2023; 33: 415\u2013425.","DOI":"10.1007\/s00062-022-01222-6"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. <i>Stroke<\/i> 2007; 38: 1531\u20131537.","DOI":"10.1161\/STROKEAHA.106.477711"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. <i>N Engl J Med<\/i> 2011; 365: 993\u20131003.","DOI":"10.1056\/NEJMoa1105335"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Alexander MJ, Zauner A, Chaloupka JC, et al. WEAVE Trial: final results in 152 on-label patients. <i>Stroke<\/i> 2019; 50: 889\u2013894.","DOI":"10.1161\/STROKEAHA.118.023996"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Alexander MJ, Zauner A, Gupta R, et al. The WOVEN trial: wingspan one-year vascular events and neurologic outcomes. <i>J Neurointerv Surg<\/i> 2021; 13: 307\u2013310.","DOI":"10.1136\/neurintsurg-2020-016208"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Gao P, Wang T, Wang D, et al. Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS randomized clinical trial. <i>JAMA<\/i> 2022; 328: 534\u2013542.","DOI":"10.1001\/jama.2022.18921"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Imamura H, Sakai N, Sakai C, et al. Japanese postmarket surveillance of percutaneous transluminal angioplasty and wingspan stenting for intracranial atherosclerotic disease. <i>World Neurosurg<\/i> 2023; 173: e48\u2013e54.","DOI":"10.1016\/j.wneu.2023.01.093"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Li H, Zhang Y, Zhang L, et al. Endovascular treatment of acute ischemic stroke due to intracranial atherosclerotic large vessel occlusion : a systematic review. <i>Clin Neuroradiol<\/i> 2020; 30: 777\u2013787.","DOI":"10.1007\/s00062-019-00839-4"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Sang H, Xie D, Tian Y, et al. Association of tirofiban with functional outcomes after thrombectomy in acute ischemic stroke due to intracranial atherosclerotic disease. <i>Neurology<\/i> 2023; 100: e1996\u2013e2006.","DOI":"10.1212\/WNL.0000000000207194"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Garayzade R, Berlis A, Schiele S, et al. Comparison of safety and efficacy after emergency stenting in patients exhibiting intracranial atherosclerotic stenosis associated with large-vessel occlusion with and without intravenous infusion of tirofiban. <i>Cardiovasc Intervent Radiol<\/i> 2023; 46: 377\u2013384.","DOI":"10.1007\/s00270-023-03372-7"}],"container-title":["Journal of Neuroendovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/19\/1\/19_ra.2024-0014\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T04:18:16Z","timestamp":1738383496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/19\/1\/19_ra.2024-0014\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5797\/jnet.ra.2024-0014","relation":{},"ISSN":["1882-4072","2186-2494"],"issn-type":[{"value":"1882-4072","type":"print"},{"value":"2186-2494","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"ra.2024-0014"}}